Transanal Endoscopic Video Assisted Rectal Lesion Resection, New Techniques Addressing Neoplasms ()
Ali Mahmood,
Javier Nieto,
Madhu Ragupathi,
Prianka Gajula
Colorectal Surgical Associates, Sugar Land, USA.
Division of Minimally Invasive Surgery, Department of Surgery, University of Texas at Houston Medical School, Houston, USA.
DOI: 10.4236/ss.2012.36060
PDF
HTML XML
3,832
Downloads
5,964
Views
Citations
Abstract
Early rectal cancer beyond the reach of conventional instruments has resulted in major abdominal and pelvic operations. As visualization is compromised beyond 6 - 8 cm, proximal to the anal verge, there have been several innovations and techniques to address T1 or T2 rectal cancer in the mid to upper rectum. Transanal Endscopic Microsurgery (TEM) was a technique that had garnered some success, however with expensive instrumentation along with limitations in instrument mobility, this technology was not applicable to many patients. Transanal Endoscopic Video Assisted (TEVA) rectal resection offers a cheap and readily accessible media to address early rectal cancer. Any hospital with standard laparoscopic ability is capable to offer TEVA rectal resection. We do advocate appropriate patient selection and advise that there is a learning curve with the increased requirement for technical difficulty. Once mastered, however, this surgical approach does provide yet another tool in the armamentarium of the surgeon.
Share and Cite:
A. Mahmood, J. Nieto, M. Ragupathi and P. Gajula, "Transanal Endoscopic Video Assisted Rectal Lesion Resection, New Techniques Addressing Neoplasms,"
Surgical Science, Vol. 3 No. 6, 2012, pp. 307-309. doi:
10.4236/ss.2012.36060.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1]
|
J. E. Krook, C. G. Moertel, L. L. Gunderson, et al., “Effective surgical adjuvant therapy for high risk rectal carcinoma,” New England Journal of Medicine, Vol. 310, 1991, pp. 737-743.
|
[2]
|
J. T. Brodsky, G. K. Richard, A. M. Cohen and B. D. Minsky, “Variables correlated with the risk of lymph node metastasis in early rectal cancer,” Cancer, Vol. 69, No. 2, 1992, pp. 322-326.
doi:10.1002/1097-0142(19920115)69:2<322::AID-CNCR2820690208>3.0.CO;2-B
|
[3]
|
G. D. Steele Jr., J. E. Herndon, R. Bleday, et al., “Sphincter-sparing treatment for distal rectal adenocarcinoma,” Annals of Surgical Oncology, Vol. 6, No. 5, 1999, pp. 433-441.
|
[4]
|
R. Bleday, E. Breen, J. M. Jessum, et al., “Prospective evaluation of local excision for small rectal cancers,” Diseases of the Colon & Rectum, Vol. 40, No. 4, 1997, pp. 388-392. doi:10.1007/BF02258381
|
[5]
|
D. M. Ota, “MD Anderson Cancer Center experience with local excision and multimodality therapy for rectal cancer,” Surgical Oncology Clinics of North America, Vol. 1, No. 1, 1992, pp. 147-152.
|